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1. Introduction 
This chapter reviews and presents the latest developments on the work on using nonionic 
microemulsions stabilized by surfactants of ethylene oxide alkyl ether type, CmEn, where m 
is the number of carbons in the alkyl chain and n is the number of ethylene oxide groups as 
models to determine the effect of an added component. We will here investigate if active 
components can be added to this model drug delivery system without them affecting the 
system. This is important as there is now several “ready to use” drug delivery systems 
where one just need to add an active component. We will here see if it is as simple as this or 
if more work will be required with these formulations. 
These model systems stems from research based at Lund University (Olsson & 
Schurtenberger, 1993) that has been thoroughly investigated and characterized (Balogh, 
Olsson & Pedersen, 2006, Balogh et al. 2007, Le et al., 1999 Leaver et al., 1994, Leaver et al., 
1995, Olsson & Schurtenberger 1993). The effect of changing the alkane (decane changed to 
hexadecane) has also been studied (Balogh et al., 2006, Balogh, Olsson & Pedersen, 2006, 
Balogh et al. 2007, Balogh & Olsson 2007). The surfactants and similar systems have been 
thoroughly investigated trough the massive work by Shinoda and Kuneida (Shinoda & 
Kunieda, 1973) in Yokohama, Japan and Kahlweit and Strey (Kahlweit et al, 1985) 
Göttingen, Germany, later Strey and Sottmann (Sottmann & Strey, 1996) with coworkers in 
Cologne, Germany. More about the early days of these surfactants and systems can be found 
in these references (Balogh et al., 2010, Lindman 2008). As with most systems the 
investigations of the phase boundaries are essential. As these systems are temperature 
sensitive through their surfactant they can change phases by just having the temperature 
changed. There is also no need for co-surfactants or co-solvents to be able to have a wide 
variety of phases. It is possible with a small number of samples to study changes into 
several phases. As the structures are thermodynamically stable one can go up and down in 
temperature to determine the boundaries more accurately. For the studied system the phase 
changes are fast and go from turbid to clear, making them easier to investigate. Amongst its 
many uses (Fanun 2009, Kunieda & Solans 1997) microemulsions have been used as drug 
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delivery systems since long time and have been investigated as such (Garti et al., 2004, 
Gupta & Moulik, 2008, Heuschkel et al., 2008, Kreilgaard et al., 2001, Lawrence & Rees, 2000, 
Spernath & Aserin, 2006) especially topical formulations (Grampurohit et al., 2011, 
Kreilgaard 2002). Nonionic microemulsions of the CmEn type has been studied regarding the 
effect of adding lidocaine (Balogh & Pedersen 2007, Balogh et al 2010). It has also been used 
as a membrane to study the effect of other analgesics on membranes (Baciu et al., 2007). 
Microemulsions are usually used to get hydrophobic active components into solution. 
Microemulsions are also reported to improve drug delivery and as such they are more than 
just a passive vehicle for the active component. It is an active vehicle that improves the 
performance of the formulation (Bagwe et al., 2001, Kogan & Garti 2006) especially on 
topical formulations (Lopes et al., 2010, Santos et al., 2008, Sintov & Levy, 2007). It is 
therefore important to study the interaction between the active component and the drug 
delivery system to better know the boundaries of the system. This gives better knowledge 
on the shelf-life of the formulations. Lidocaine is amongst other used as local anesthetic in 
dermal creams and is as such, a good candidate as a model drug for a drug delivery system 
aimed for topical delivery. It is well known that having a hydrophobic compound, which is 
sensitive to oxidation, in a microemulsion or an emulsion help protect this compound 
(Gaonkar & Bagwe, 2002). It is also possible to have extra protection by having antioxidant 
in the system and if formulated well one can have antioxidants in both the oil- and water 
phase. Antioxidants have now also become a component that is added to many 
formulations to act as active component and not only to protect other components. This is 
extra common in skin products where vitamin E is a component that helps sell the products, 
often labeled as tocopherol acetate, tocopheryl linoleate or tocopheryl nicotinate (Nabi et al., 
1998). Some studies have shown that applying vitamin E before UV exposure significantly 
reduces acute responses such as edema and erythema (Bissett et al., 1992). Topical 
application is related to decrease of the incidence of ultraviolet UV-induced skin cancer 
(Krol et al., 2000, McVean & Liebler, 1999). The form of vitamin E that is preferentially 
absorbed and accumulated in humans is α-tocopherol (Rigotti, 2007). These formulations 
show many similarities to the model system used here. There is also a trend with “natural” 
antioxidants in many kinds of products from juices to shampoos and skin products. One fairly 
available antioxidant is chlorogenic acid, a polyphenol with a dry matter content in coffee 
beans on 4-14% depending on coffee species (Clifford et al., 1985, De Maria et al., 1994, Ky et 
al., 2001, Trugo & Macrae, 1984). From the chlorogenic acids family (caffeoylquinic acids), the 
most reported isomers are, 3-CQA, 4-CQA and 5-CQA. 5-CQA is the most abundant 
compound found in coffee beans, responsible for about 56-62 % of total chlorogenic acids 
(Ramirez-Colonel et al., 2004, Ramirez-Martinez 1988). It is also the most abundant antioxidant 
in coffee foliage (Marques, 2011). It has been getting a lot of attention and the reported health 
benefits both in vivo and in vitro, from chlorogenic acids are hepatoprotective, 
immunoprotective, hypoglycemic and antiviral activities (Basnet et al., 1996, Natella et al., 
1998, Scalbert & Williamson, 2000). We are using 5-CQA as our type chlorogenic acid. 
Phase studies give a lot of essential information about the system and it has even been done to 
make sure that the batch of surfactant used is good by constructing a known phase diagram. 
With three ingoing components and temperature the full spectra of the systems could be 
illustrated with a phase prism. To optimize the ratio between work and information some cuts 
(fixing ratios of components) have been used. Three classic ones are the Shinoda cut (Kunieda & 
Shinoda, 1982) with fixed surfactant ratio varying the water to oil ratio, to investigate the 
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reversal of the system amongst others, the Kahlweit cut (Kahlweit & Strey, 1985) with fixed 
water to oil ratio often 1:1 on volume base, to investigate the efficiency of the surfactant 
amongst others, and the Lund cut (Olsson & Schurtenberger, 1993) with fixed ratio of surfactant 
to oil, often 0.815:1, to study the microemulsion aggregates concentration dependence. The 
Kahlweit cut is also known as the fish or the fishtail cut due to shape of the 3-phase body and 
the microemulsion phase. Even though the Lund cut is from the nineties it is only named 
recently (Balogh, 2010, Balogh et al., 2010). The phase cuts are illustrated in Figure 1. 
 
Fig. 1. Phase cuts. Here three different phase cuts are illustrated from the Shinoda cut on the 
left with the Kahlweit in the middle and the Lund cut to the right. T stands for temperature, 
W for water, O for Oil and S for Surfactant. 
With these systems there are some trends that can be used to help in determining a new 
system and there is also some scaling. For the Lund system using alkanes and C12E5 the 
trend is that the lowest temperature where one can have microemulsions, TEFB, increases 
with the length of oil from octane to octadecane. The microemulsion temperature range, the 
temperature increase one can do from TEFB and still have 1-phase microemulsion, decreases 
with increased oil length (Balogh, 2010, Balogh et al., 2010). This is a general finding for all 
these systems. There have also been reports on the lamellar phase and that it is not only 
becoming smaller but actually withdrawing gradually to high concentrations only, with 
aggregates volume fractions above 0.5 (Balogh, Olsson & Pedersen, 2006, Balogh, 2011). We 
have not seen reports if this is a general finding for these types of systems or not. 
2. Result 
We will here present the standard system comprised of C12E5, decane and water (surfactant, 
oil and water) with phase studies and then diffusion studies both at the emulsification 
boundary and at elevated temperatures. We will then present the systems with an extra 
added component both phase studies, studies of the zeta potential and diffusion and 
compare with the standard system. This will be followed by the studies of the antioxidant 
activity both individually in the microemulsion compared to in a pure solvent and together 
in the microemulsion. 
2.1 Studies of the system C12E5 decane and water 
The samples were performed prior to using by diluting a stock-solution of surfactant and oil 
(C12E5:decane 0.815:1 on volume base) with water in the water rich region. The stock-
solution volume fraction, Ф, stretched the 0.005-0.2 region but was mostly investigated in 
the 0.05-0.2 region. The samples where then mixed above the upper phase boundary (turbid 
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two-phase region) for five minutes and then cooled while stirred into the microemulsion 
region (clear one-phase solution). They were stored at this temperature until used. 
2.1.1 Phase studies of the system C12E5 decane and water 
We will here present mostly work using the original type system for the Lund cut, C12E5, 
decane and water. A phase diagram for the microemulsion phase that we are working in is 
shown in Figure 2. 
 
Fig. 2. Partial phase diagram for the standard system (C12E5, decane and water) showing the 
upper (spheres) and lower phase boundaries (squares) temperatures for the microemulsion 
phase in the water rich region with the surfactant and oil concentrations from Ф = 0.005 to 0.2.  
A comprehensive phase diagram has been determined earlier (Le et al., 1999). This shows 
that above the microemulsion phase is a lamellar phase and even further up in 
temperature is a bicontinuous bilayer phase. At higher concentrations just above volume 
fractions of 0.4 starts liquid crystalline phases like cubic and hexagonal. We have been 
working in a more limited area of the range mostly in the microemulsion phase with 
aggregate ratios, Ф, mostly from 0.05 to 0.2. This is done to have as little impact from 
crystalline structures at higher concentrations and from the edge of the dilution limit as 
possible. It can be hard to follow the system visually at the highest dilutions with Ф, from 
0.005 to 0.02 as they tend to look “clear” even when there is two phases. Initially at the 
lower phase boundary it starts as discrete aggregates that, at the lower concentrations, are 
spherical and towards the upper boundary the system becomes bicontinuous. The higher 
the concentration the lower is the increase in temperature needed to change into 
bicontinuous system (Balogh & Olsson, 2007, Balogh et al. 2007, Leaver et al., 1994, Leaver 
et al., 1995). The change happens without macroscopic phase change. 
2.1.2 Diffusion studies of the system C12E5, decane and water 
With increased temperature the curvature of the surfactant film decreases. As long as one is 
below the lower emulsification boundary and thus has access to more oil, the aggregates 
essentially just grow as spheres and become bigger spheres. So at the emulsification 
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boundary the aggregates are spherical at least at lower concentrations. At higher 
concentrations and especially for longer oils the aggregates become slightly elongated 
already at the emulsification temperature (Balogh, Olsson & Pedersen, 2006). The growth of 
these aggregates has been shown to best fit with the one-dimensional ellipsoidal growth 
(rugby ball) (Leaver et al., 1995). The growth before changing into bicontinuous does not 
extend axis ratios of 4-6 big axis to small axis (Balogh & Olsson, 2007, Balogh et al. 2007, 
Leaver et al., 1994, Leaver et al., 1995). Earlier reports of elongated micelles did not 
investigate if the aggregates had changed into the bicontinuous phase as defined by the self 
diffusion of the surfactant being different from that of oil (for an oil-in-water system). The 
behavior in scattering terms of the bicontinuous system is initially such that it easily could 
be confused with elongated micelles. As there is no macroscopic phase change it is not seen 
any change when performing phase studies of the microemulsion phase. When performing 
light scattering experiments one need to remember that for dynamic light scattering one is 
studying collective diffusion. Collective diffusion has a concentration dependence that 
makes it important to have in mind when comparing different concentrations. It also means 
that the size coming from the light scattering machine has not taken this into account as it 
just using the Stokes Einstein equation to get size from diffusion. 
 0 6
bK TD
r  (1) 
Here D0 is the diffusion at infinite dilution, kB boltzmann constant, η viscosity and r radius 
of the aggregate. From this it is easy to see how the size depends on the diffusion in this case 
at infinite dilution and with spherical aggregates. 
 
Fig. 3. Diffusion versus temperature for five droplet concentrations from Ф = 0.05 to 0.2.  
When looking at Figure 3 for one temperature it seems as if the higher the concentration the 
higher the diffusion. Just applying Stokes Einstein equation would give smaller size with 
higher concentration. This is however not the case as we will show. If one want to compare 
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different concentrations it is important that one have the concentration dependence of the 
collective diffusion in mind. The hard sphere behavior (if there is no growth in the system or 
repulsion/attraction between the aggregates) is DC/D0= 1+ФHS*1.45. Where DC is the 
collective diffusion, D0 is the diffusion at infinite dilution and ФHS the hard sphere volume 
fraction, for these systems 1.14 times that of the aggregate volume fraction (Olsson & 
Schurtenberger, 1993). If the result is presented as the diffusion normalized with the 
diffusion at infinite volume fraction at each temperature (to just have the effect of 
concentration at each temperature), as in Figure 4, one can see that the difference from the 
hard sphere behavior is bigger at higher temperatures and concentrations. It has earlier been 
shown that there is no attraction in these systems that would explain this so the only 
explanation left is that the aggregates grow. This has been shown to be the case (Balogh & 
Olsson, 2007, Balogh et al. 2007, Leaver et al., 1994, Leaver et al., 1995). At higher 
temperatures the aggregates are more elongated and also becomes bicontinuous so that the 
diffusion do not give a good representation of the aggregate size just some form of repeated 
unit in the structure and the perceived diffusion may even go up. 
 
Fig. 4. Diffusion versus droplet concentration from Ф = 0.05 to 0.2 for several temperatures 
with the collective diffusion behavior for aggregates acting like hard spheres as reference. 
Just to once again mention the effect of changing the alkane one would see the same thing as 
in Figure 4 that the higher temperature the faster they grow with concentration but with 
increasing chain length. This is seen as the slope of the fitted line would be lower and 
further away from the hard sphere behavior with increasing chain length or temperature 
(Balogh, Olsson & Pedersen 2006, Balogh, 2011).  
2.2 Studies of the system C12E5, decane and water with an added component 
As the model system is well characterized it is easier to study the effect of adding a fourth 
component to the system especially if one will work with limited number of techniques. 
Generally the systems used for drug delivery are more complex and often not studied as 
thoroughly as our model. The findings from an applied system need to be complemented 
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with more techniques to explain what happen on aggregate level. The addition of three 
different components has been studied. The components are different as one is a local 
anesthetic, oil soluble and slightly water soluble (20:1 solubility in decane:water) and the 
other two are natural compounds that act as antioxidants. The antioxidants are different as 
chlorogenic acid, CQA, is water soluble and -tocopherol is oil soluble. The molecular 
structures are shown in Figure 5. 
 
Fig. 5. Molecular structure for the added components. From left to right chlorogenic acid, -
tocopherol and lidocaine.  
To try to keep the lipophilic component constant part of the oil was substituted with 
lidocaine and α-tocopherol respective. The system was close to the limit of how much that 
could be solved with 10% volume fraction of lidocaine in decane. When adding the 
surfactant it was no problem to keep it in solution, even in the fridge. The solubility of 
lidocaine in water was low but there was some solubility estimated to 0.5% giving a ratio of 
solubility between decane and water to 20:1. There was no problem in solving 10 volumes 
percent of α-tocopherol in decane. We dissolved a maximum of 2% CQA in water. 
Tocopherol had very low solubility in water and is often reported as insoluble in water. The 
solubility of CQA in decane was low. We used the oil with the added substance as “oil” 
when preparing our stock solution and used water containing CQA to dilute the stock 
solution when preparing our measurements. From this it is seen that the concentration of 
CQA was almost constant regardless of the aggregate concentration (giving different ratio). 
We added 1, 5 and 10 volume percent of lidocaine giving the active compound content of 
the total system of 1% with a 10% addition and with an aggregate fraction of 0.2. The local 
analgesic EMLA® from AstraZeneca contains 2.5% lidocaine so the concentrations used are 
similar to the formulations used today. Concentrations of 2% CQA are much higher than 
that of coffee and with a maximum of 1% of -tocopherol on total formulation it seems to be 
above what is used in formulations today. 
2.2.1 Phase studies of the system C12E5, decane and water with an added component 
The first thing that needs to be done was to perform phase studies and determine the phase 
diagram with the additions. In Figure 6 we show the temperature of the lower phase 
boundaries for different droplet concentrations and different addition of CQA. There is a 
small but increasing difference in temperature with droplet concentration much more than 
in the standard and for the other additions. 
As the concentrations of the antioxidant components are relatively high compared to many 
formulations, it was necessary to also study the effect at lower concentrations and for 
concentrations CQA 0.005-0.02% the change from standard was small. From here it is seen that 
not only the temperature where the microemulsion form changes, but also the upper boundary. 
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However the upper boundary does not increase as much as the lower giving a smaller 
microemulsionrange. The range becomes smaller with higher CQA concentration (and by that 
the temperature of the emulsification boundary). A similar thing has been seen in system where 
the oil length has been varied, the lower the temperature the bigger the range. This gives that 
shorter alkanes has bigger microemulsion temperature range than the longer ones. 
  
Fig. 6. Partial phase diagram in the water rich region showing the upper (spheres) and 
lower phase boundaries (squares) for the microemulsion phase with the surfactant and oil 
concentrations from Ф = 0.005 to 0.2 and with 0.05-2% of water substituted with 
chlorogenic acid.  
Phase investigations were also performed for the system with added lidocaine. As can be 
seen in Figure 7 there is a significant change when increasing the substitution. 
 
Fig. 7. Partial phase diagram in the water rich region showing the upper (spheres) and lower 
phase boundaries (squares) for the microemulsion phase with the surfactant and oil 
concentrations from Ф = 0.005 to 0.2 and with 1, 5 and 10% of the oil substituted with 
lidocaine.  
www.intechopen.com
Nonionic Model Microemulsions to Study  
Interactions with Active Components and Antioxidant Activity 123 
The phase boundaries of the standard system are very close to that of a 1% substitution with 
lidocaine. One can also see that with increasing aggregate concentration the phase 
boundaries are lowered slightly. 
Finally phase investigations were performed on the systems with added -tocopherol and 
below are shown the resulting phase diagram in Figure 8.  
 
Fig. 8. Partial phase diagram in the water rich region with the surfactant and oil 
concentrations Ф = 0.05 and 0.15 with 5 and 10% of the oil substituted with -tocopherol.  
 
Fig. 9. Partial phase diagram in the water rich region with the surfactant and oil 
concentrations fixed at Ф = 0.15 with varied amount of the oil substituted with -tocopherol 
and lidocaine, and water substituted with CQA.  
Here there is a slight increase of phase boundaries with temperature. The substitution with 
-tocopherol makes a bigger impact than the same substitution with lidocaine. The 
temperatures of the phase boundaries are lowered far from the standard system with 298 as 
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lower boundary and for 5% substitution this is above its upper phase boundary. This 
dramatic phase change needs to be addressed when formulating with this high 
concentrations. Below Figure 9 is showing that the lower phase boundary of CQA is 
increasing the temperature and that lidocaine and especially -tocopherol is lowering the 
temperature. Here, all of the data is for a droplet ratio of 0.15. 
The increase caused by the substitution with CQA is big compared to the others looking at 
their part of the solvent. As there is more water than decane the change with number of 
molecules are similar between CQA and -tocopherol but higher than that of lidocaine. 
2.2.2 Zeta potential studies for the system C12E5, decane and water with an added 
component 
The effect of the substitution with CQA was very strong and in order to try to find out 
why, more investigations were performed. As CQA can be charged in water the 
possibility of the aggregates also being charged was investigated. Zeta potential 
measurements were performed and a small Zeta potential was noted. The standard 
system did not show any zeta potential. To study if it was a “real effect” and not just a 
coincidence repeated experiments were performed varying the concentrations of the 
ingoing components. Figure 10 shows the fixed concentration of CQA and the variation of 
the aggregate concentration. 
 
Fig. 10. Zeta potential for different aggregate concentrations with fixed 1 % CQA 
concentration (triplicate measurements, and standard deviation in the error bars).  
As can be clearly seen there is a concentration dependence and the aggregates with most 
charges are also the ones that has most CQA per aggregate (lower droplet concentrations). 
To be certain of the effect we also varied the CQA concentration and had fixed aggregate 
concentration. This is shown in Figure 11. 
Here one can also see the relation with charge of the aggregate and the CQA concentration. 
From here it is evident that the aggregates behave as if they are charged. Up to a bulk 
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concentration of 2% the concentration in the bulk influence the apparent charge of the 
aggregate. If the charge is connected to the aggregate or if it is several charges that shift and 
by its close presence to the aggregate make it appear charged is not determined yet. It was 
not enough to have a charged bulk water to get aggregates that appeared to be charged, as 
was seen when using sodium chloride with the same charge (Balogh et al., 2012). This had 
no or minimum effect on the phase boundaries, the zeta potential (had none) and the 
diffusion compared to the standard system. Lidocaine did not show any effect on the zeta 
potential even if it had some solubility in water. Tocopherol was not studied as it has so low 
solubility in water that we did not expect to see any effect. 
 
Fig. 11. Zeta potential for different CQA concentrations with fixed aggregate concentrations 
Ф=0.05 (triplicate measurements, and standard deviation in the error bars).  
2.2.3 Diffusion studies for the system C12E5, decane and water with an added 
component 
The diffusion of the system with added compounds did change a bit from standard part of 
it, which was due to the different temperature range of the microemulsion phase and by that 
the measuring temperature. To eliminate this temperature effect the curves where 
normalized with their respective diffusion at the temperature of lower phase boundary. 
Then one can see that the curves also are slightly different as can be seen from Figure 12. 
Here one can look at the shape of the curve and compare to see that they have a very similar 
behavior. For small additions it was hard to see any significant difference but at higher 
concentrations the profile is slightly different showing that the growth of the aggregates and 
the temperatures where the systems change into bicontinuous aggregates differs from that 
of the standard system.  
The small differences in how these systems behave with temperature, and hence when they 
change from discrete aggregates to a bicontinuous system, may influence a lot of properties 
for a formulation, such as the availability of drug and stability of the formulation, and thus 
important parameters to be aware of. 
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Fig. 12. Relative diffusion the collective diffusion normalized with the diffusion at the 
respective phase boundary temperature for several systems with added components. 
2.3 Studies of the antioxidant properties in the microemulsion 
Even though antioxidants can be used to manipulate the phase boundaries, their primary 
function would be to act as antioxidants either to protect an active component or 
themselves as main components. It was hence important to confirm that the antioxidants 
still had the capability to interact with oxidants if these would appear in the 
microemulsion. We determined the antioxidant activity by using a dye that is a radical 
2,2-diphenyl-1-picrylhydrazyl (DPPH) hence after called DPPH. The structure of DPPH is 
shown in Figure 13 
 
Fig. 13. The molecular structure of 2,2-diphenyl-1-picrylhydrazyl (DPPH) and then when it 
has reacted with another radical. 
The problem is to have a system where a dye can be used to test both hydrophobic and 
hydrophilic compounds. DPPH is soluble in methanol and in decane and it fits our purpose. 
An added dye may influence the phase boundaries but at the concentrations used here, up 
to 60 µmol/L, there were no significant changes. First a calibration curve of DPPH was 
prepared. Then the values after the addition of antioxidant were compared to this to get the 
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concentration. As DPPH is a strong dye, the concentrations that could be used and still be in 
the region where there is a good linear correlation between absorption and concentration, 
was quite low as stated earlier (up to 60 µmol/l). This also influenced the maximum 
concentrations of the antioxidants. It was also possible to use DPPH in decane used to 
prepare the stock solution for the microemulsion experiments. 
2.3.1 Studies of the antioxidant properties of CQA in the microemulsion 
We could determine the effect of CQA with DPPH in a methanol solution and then compare 
that with the effect in the microemulsion. In the microemulsion we dissolved the DPPH in 
the decane used in our microemulsion and CQA was in the water used to dilute the 
microemulsion stock solution. This way we did not need to add anything that would 
influence the microemulsion more than the dye itself. The dye was in such low 
concentrations that it did not influence the microemulsion phase boundaries. We were 
somewhat limited in the amount of DPPH we could have in the decane for the 
microemulsion but not significantly and we were able to have a good concentration interval. 
Even though DPPH was in decane and CQA in water, CQA had the same effect as if both 
were in methanol as seen in Figure 14.  
 
Fig. 14. The decay in DPPH as a function of the CQA concentration both in methanol and in 
microemulsion. 
This shows the exchange between the inside of the microemulsion aggregate and the 
surrounding water. It also shows that the antioxidant is as effective (if any difference even 
slightly better) in the microemulsion as in the pure solvent methanol. 
2.3.2 Studies of the antioxidant properties of -tocopherol in the microemulsion 
For -tocopherol we could have it dissolved in the decane used for the microemulsion 
and had one other microemulsion with DPPH and just mixing these two microemulsions 
gave us a system with both components. This gave the same effect as if having them 
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mixed in two pure decane solutions as seen in Figure 15. We could not have twice as high 
concentration of DPPH in one of the microemulsions to get the same initial concentration 
when mixed so that is why the concentration is lower. The concentration absorbance 
behavior is the same. The effect in the microemulsion is as good as in the solvent, if 
anything even slightly better. So this once again shows that there is an interchange 
between the inside and outside of the aggregates. 
 
Fig. 15. The decay in DPPH as a function of the -tocopherol concentration both in decane 
and in microemulsion. 
Once again we showed how there is an exchange between the microemulsion aggregate and 
the bulk. This is even a good visual way of showing how a purple solution mixed with a 
clear can become almost clear solution with a brownish color. 
2.3.3 Studies of the antioxidant properties of CQA and -tocopherol in the 
microemulsion 
Having showed that the two antioxidants worked well in the microemulsion when used 
individually the natural next step is to use them together. Like that there is a bonus in 
that they have opposite effect on the curvature and hence have smaller effect on the 
microemulsion boundaries. This was not an issue in the concentration range we used to 
be able to study the antioxidant effect as the concentrations were so low that they did not 
have any significant effect. If one would use much higher concentrations in formulations 
this would however be an advantage. It has earlier been reported that there is an 
additive effect by having these two antioxidants but that was for a reverse system (Sim et 
al., 2009). Our microemulsion is as previously stated oil-in-water in this temperature 
range. To study the antioxidant-effect an -tocopherol and CQA 1:1 containing 
microemulsion was mixed with a microemulsion containing DPPH. The effect of total 
antioxidant versus absorption is shown in Figure 16 and from this it is shown that the 
antioxidants work well together. 
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Fig. 16. The decay in DPPH as a function of the antioxidant concentration for CQA, -
tocopherol and the two combined.  
By just comparing the decay it is seen how the two antioxidants can work together and by 
that have the same and even stronger effect with 1/4 extra compared to their individual 
contribution. This is seen by their decay of -0.027 compared to the average of -0.0160 for 
CQA and -0.0198 for -tocopherol. As the two antioxidants has reverse effect on the phase 
boundaries more can be added and still have the temperature range of the model 
microemulsion. 
3. Conclusion 
We have here illustrated how convenient it is to use a model system to determine the effect 
of some added components to a microemulsion. We have shown both macroscopic and 
microscopic changes in the systems when adding these compounds. These properties of 
influencing the microemulsion would severely influence the use of the drug delivery 
system. Even if the macroscopic temperature effect is taken into consideration, the effect on 
the microscopic properties are important for properties like drug load and shelf-life. This 
shows the importance of always performing phase studies of the involved systems when 
adding components. It also shows the importance to investigate what happens with the 
system when it is loaded with an active component to see how it differs from a system 
without the drug. This may be masked to some degree by the more complex systems used 
today. These systems have much less temperature dependence so therefore the need to 
sometimes use model systems to better see the changes. We have seen how a hydrophobic 
compound, -tocopherol, a hydrophilic compound, CQA, and a compound that is mostly 
hydrophobic but has a solubility in water as well (20:1 solubility in decane compared to 
water), lidocaine influence the phase boundaries on the microemulsion. If one uses the ratio 
of surfactant tail to head as the reason for the curvature of the aggregate one can see the 
effect of adding these compounds as the effect they have on tails or the heads and in the case 
of lidocaine tails and to a small extent even the heads. This is illustrated in Figure 17. 
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Fig. 17. Effect on the curvature of the surfactant film of the different components. The 
ingoing components are not set to scale. Here the micelle is shown and the close up of the 
surfactant and their interaction with water and oil standard system (A), the system with 
added CQA (B) and system with added tocopherol (C).  
It is not determined yet if this is due to the penetration or general proximity to the heads 
and tails, but we know that it is not caused by the bulk charge in the case of CQA as sodium 
chloride at the same concentration did not have any significant effect. 
Apart from the changes in phase boundary temperatures, the addition of these compounds 
also influence the temperature increase needed to change into a bicontinuous 
microemulsion and the growth with temperature and concentration. This influence may be 
important to be aware of when formulating so that it can be taken into consideration when 
planning. One can also use antioxidants in the microemulsions and they have the same 
effect as if they would be used in a pure solvent both for a hydrophobic compound as -
tocopherol and a hydrophilic compound as CQA. We have with these experiments also 
illustrated that there is an interchange between the inside of the aggregate and the outside. 
Having a microemulsion or even an emulsion makes it possible to use both hydrophobic 
and hydrophilic antioxidants and by this have a more complex protection. This also 
minimizes the effect on the phase boundaries as they have reverse effect. The combination of 
the two antioxidants showed a synergetic effect of ¼. To further improve the knowledge one 
would like to study the specific interactions which the components have with the surfactant 
film. One would also use more substances in order to have a predictive quantitative model 
and not only a qualitative model. It would also be interesting to do long term tests with 
antioxidants and components that are sensitive to oxidation. This would eliminate any 
problem with an added dye. 
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